Correlation Between Fate Therapeutics and Arcellx
Can any of the company-specific risk be diversified away by investing in both Fate Therapeutics and Arcellx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fate Therapeutics and Arcellx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fate Therapeutics and Arcellx, you can compare the effects of market volatilities on Fate Therapeutics and Arcellx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fate Therapeutics with a short position of Arcellx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fate Therapeutics and Arcellx.
Diversification Opportunities for Fate Therapeutics and Arcellx
0.1 | Correlation Coefficient |
Average diversification
The 3 months correlation between Fate and Arcellx is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Fate Therapeutics and Arcellx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arcellx and Fate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fate Therapeutics are associated (or correlated) with Arcellx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arcellx has no effect on the direction of Fate Therapeutics i.e., Fate Therapeutics and Arcellx go up and down completely randomly.
Pair Corralation between Fate Therapeutics and Arcellx
Given the investment horizon of 90 days Fate Therapeutics is expected to under-perform the Arcellx. In addition to that, Fate Therapeutics is 1.89 times more volatile than Arcellx. It trades about -0.15 of its total potential returns per unit of risk. Arcellx is currently generating about -0.01 per unit of volatility. If you would invest 8,276 in Arcellx on September 27, 2024 and sell it today you would lose (518.00) from holding Arcellx or give up 6.26% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Fate Therapeutics vs. Arcellx
Performance |
Timeline |
Fate Therapeutics |
Arcellx |
Fate Therapeutics and Arcellx Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Fate Therapeutics and Arcellx
The main advantage of trading using opposite Fate Therapeutics and Arcellx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fate Therapeutics position performs unexpectedly, Arcellx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arcellx will offset losses from the drop in Arcellx's long position.Fate Therapeutics vs. Atara Biotherapeutics | Fate Therapeutics vs. Sana Biotechnology | Fate Therapeutics vs. Caribou Biosciences | Fate Therapeutics vs. Arcus Biosciences |
Arcellx vs. Nuvalent | Arcellx vs. Ventyx Biosciences | Arcellx vs. Amylyx Pharmaceuticals | Arcellx vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |